Clinical Trial Update: Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial assesses maintenance therapy with selinexor plus azacitidine after allogeneic stem cell transplantation in patients with NK/T-cell lymphoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer T-cell Lymphoma

Drugs mentioned

• Vidaza (azacitidine) (azacitidine)
• XPOVIO (selinexor) (selinexor)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: NK T-Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING